Blue Jet Healthcare Limited (NSE:BLUEJET)
India
· Delayed Price · Currency is INR 865.00
-4.65 (-0.53%)
Jun 27, 2025, 3:30 PM IST
Blue Jet Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| 10,300 | 7,116 | 7,210 | 6,835 | 4,989 | Upgrade
| |
Revenue Growth (YoY) | 44.74% | -1.30% | 5.49% | 36.99% | -7.29% | Upgrade
|
Cost of Revenue | 4,612 | 3,212 | 3,427 | 2,946 | 1,695 | Upgrade
|
Gross Profit | 5,688 | 3,904 | 3,783 | 3,889 | 3,295 | Upgrade
|
Selling, General & Admin | 609.97 | 531.85 | 418.97 | 330.3 | 289.55 | Upgrade
|
Other Operating Expenses | 837.81 | 1,080 | 1,173 | 1,066 | 944.67 | Upgrade
|
Operating Expenses | 1,626 | 1,893 | 1,843 | 1,614 | 1,431 | Upgrade
|
Operating Income | 4,062 | 2,011 | 1,940 | 2,275 | 1,864 | Upgrade
|
Interest Expense | -0.98 | -1.61 | -13.59 | -32.82 | -46.91 | Upgrade
|
Interest & Investment Income | - | 28.18 | 5.87 | 4.38 | 6.16 | Upgrade
|
Currency Exchange Gain (Loss) | - | 99.27 | 147.66 | 167.53 | 46.22 | Upgrade
|
Other Non Operating Income (Expenses) | - | 14.34 | 13.89 | 2.38 | -5.06 | Upgrade
|
EBT Excluding Unusual Items | 4,061 | 2,152 | 2,094 | 2,417 | 1,864 | Upgrade
|
Gain (Loss) on Sale of Investments | - | 142.09 | 71.11 | 19.36 | 34.28 | Upgrade
|
Gain (Loss) on Sale of Assets | - | 4.72 | 1.03 | 0.29 | 1.04 | Upgrade
|
Asset Writedown | - | - | - | -3.85 | - | Upgrade
|
Other Unusual Items | - | -97.43 | - | - | -53.07 | Upgrade
|
Pretax Income | 4,061 | 2,201 | 2,166 | 2,432 | 1,847 | Upgrade
|
Income Tax Expense | 1,009 | 563.44 | 565.84 | 616.39 | 488.7 | Upgrade
|
Earnings From Continuing Operations | 3,052 | 1,638 | 1,600 | 1,816 | 1,358 | Upgrade
|
Minority Interest in Earnings | - | - | - | - | 26.28 | Upgrade
|
Net Income | 3,052 | 1,638 | 1,600 | 1,816 | 1,384 | Upgrade
|
Net Income to Common | 3,052 | 1,638 | 1,600 | 1,816 | 1,384 | Upgrade
|
Net Income Growth | 86.38% | 2.33% | -11.88% | 31.19% | -4.44% | Upgrade
|
Shares Outstanding (Basic) | 174 | 173 | 173 | 173 | 173 | Upgrade
|
Shares Outstanding (Diluted) | 174 | 173 | 173 | 173 | 173 | Upgrade
|
Shares Change (YoY) | 0.03% | - | - | - | - | Upgrade
|
EPS (Basic) | 17.59 | 9.44 | 9.23 | 10.47 | 7.98 | Upgrade
|
EPS (Diluted) | 17.59 | 9.44 | 9.23 | 10.47 | 7.98 | Upgrade
|
EPS Growth | 86.33% | 2.33% | -11.88% | 31.19% | -4.44% | Upgrade
|
Free Cash Flow | -341.15 | 683.96 | 822.85 | 1,246 | 971.62 | Upgrade
|
Free Cash Flow Per Share | -1.97 | 3.94 | 4.74 | 7.18 | 5.60 | Upgrade
|
Dividend Per Share | 1.200 | 1.000 | - | - | - | Upgrade
|
Dividend Growth | 20.00% | - | - | - | - | Upgrade
|
Gross Margin | 55.22% | 54.86% | 52.47% | 56.89% | 66.04% | Upgrade
|
Operating Margin | 39.44% | 28.27% | 26.91% | 33.29% | 37.36% | Upgrade
|
Profit Margin | 29.63% | 23.01% | 22.20% | 26.57% | 27.74% | Upgrade
|
Free Cash Flow Margin | -3.31% | 9.61% | 11.41% | 18.23% | 19.47% | Upgrade
|
EBITDA | 4,240 | 2,275 | 2,148 | 2,484 | 2,059 | Upgrade
|
EBITDA Margin | 41.16% | 31.98% | 29.80% | 36.35% | 41.28% | Upgrade
|
D&A For EBITDA | 177.89 | 264 | 208.11 | 209.35 | 195.52 | Upgrade
|
EBIT | 4,062 | 2,011 | 1,940 | 2,275 | 1,864 | Upgrade
|
EBIT Margin | 39.44% | 28.27% | 26.91% | 33.29% | 37.36% | Upgrade
|
Effective Tax Rate | 24.84% | 25.60% | 26.12% | 25.34% | 26.46% | Upgrade
|
Revenue as Reported | 10,762 | 7,405 | 7,449 | 7,029 | 5,078 | Upgrade
|
Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.